On August 13, Dongping County Ecological Environment Bureau accepted and publicized the Environmental Impact (EI) Report of Shandong Xiangrui Pharmaceutical Co. Ltd. (Shandong Xiangrui)’s 300,000 t/a monosodium glutamate project.
Project overview
- Type of project: New construction
- Total investment: USD123 million (RMB888.07 million)
- Construction contents: construction of production plants, tanks and other facilities, using existing engineering products (glucose, corn syrup) as raw materials, the production of 300,000 t/a monosodium glutamate and 30,000 t/a mycelium protein (by-products).
- Labor quota: 200 people, transferred from existing employees, working 333 days, 8000hours per year.
The current capacity of Shandong Xiangrui is consuming 364,800 t/a of corn to produce 240,000 t/a of corn starch, 200,000 t/a of pharmaceutical-grade glucose, 120,000 t/a of anhydrous glucose, 20,000 t/a of food-grade glycerol, and so on.
For more information on China’s corn deep-processing industry, check out NK Corn Deep-Processing China News or email us at contact@nkmarketresearch.com.
